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Abstract: Owing to its redox properties, copper is a cofactor of enzymes that catalyze reactions 
in fundamental metabolic processes. However, copper-oxygen interaction, which is a source of 
toxic oxygen radicals generated by the Fenton reaction, makes copper a doubled-edged-sword in 
an oxygen environment. Among the microelements influencing male fertility, copper plays a special 
role because both copper deficiency and overload in the gonads worsen spermatozoa quality and 
disturb reproductive function in mammals. Male gametes are produced during spermatogenesis, 
a multi-step process that consumes large amounts of oxygen. Germ cells containing a high amount of 
unsaturated fatty acids in their membranes are particularly vulnerable to excess copper-mediated 
oxidative stress. In addition, an appropriate copper level is necessary to initiate meiosis in premeiotic 
germ cells. The balance between essential and toxic copper concentrations in germ cells at different 
stages of spermatogenesis and in Sertoli cells that support their development is handled by a network 
of copper importers, chaperones, recipient proteins, and exporters. Here, we describe coordinated 
regulation/functioning of copper-binding proteins expressed in germ and Sertoli cells with special 
emphasis on copper transporters, copper transporting ATPases, and SOD1, a copper-dependent 
antioxidant enzyme. These and other proteins assure copper bioavailability in germ cells and 
protection against copper toxicity.
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1. Introduction
Copper (Cu) is a trace element necessary for the growth and development of all living organisms 
and is the third most abundant trace element in the body after iron and zinc [1]. In an organism, 
this reactive element can exist in two oxidation states: as a reduced, cuprous (Cu+) and as 
an oxidized, cupric (Cu2+) ion [2] . The extensive range of redox potentials of copper and its capacity 
to participate in one-electron transfer reactions determine the biological activity and function of 
this microelement. Owing to its redox properties, copper is a cofactor for more than 30 enzymes. 
Many Cu-dependent enzymes catalyze reactions used in fundamental metabolic processes including 
respiration (cytochrome c oxidase), detoxication of oxygen free radicals (superoxide dismutases: 
SOD1 and SOD3), connective tissue formation (lysyl oxidase), neurotransmitter synthesis (dopamine 
ß-hydroxylase and peptidylglycine-amidating monooxygenase, PAM), pigment production (tyrosinase), 
and iron metabolism (ceruloplasmin and hephaestin) [3- 5]. Copper also takes part in the processes 
of myelination and regulation of the circadian rhythms, and is necessary for angiogenesis and
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coagulation [6]. Copper deficiency leads to the impaired function of these enzymes and in consequence 
to disturbances in the key metabolic processes. Conversely, by means of the same redox activity, 
copper can generate an extremely harmful hydroxyl radical ( OH) through the Fenton reaction [7], 
which may cause oxidative damage to proteins and nucleic acids, lipid peroxidation, and enzyme 
inhibition. For this reason, excess copper is highly toxic to organisms [2,3,7]. To deal with this dual 
nature of copper, tightly regulated molecular mechanisms have evolved and operate in organisms to 
ensure its bioavailability and to reduce its toxicity. The balance between essential and toxic copper 
concentrations at both cellular and systemic levels is maintained by a complex network of proteins 
involved in the regulation of copper uptake, transport, utilization, storage, and excretion.
2. An Outline of Systemic Copper Metabolism in Mammals
In adult mammals, copper is predominantly absorbed in the duodenum and small intestine and is 
transported to the blood from enterocytes. In adult humans, the average daily intake of copper ranges 
from 0.8 to 3 mg [3,4,8]. In the blood, absorbed copper is bound to albumin, histidine, or glutathione, 
and is then transported via the portal vein into the liver, a central organ that maintains copper 
homeostasis [3,4]. In hepatocytes, copper is bound to ceruloplasmin (CP) and is again excreted to the 
circulatory system, and with blood redistributed to other organs and tissues [9,10]. CP is a main copper 
carrier in the blood, transporting this microelement to various organs and tissues. Approximately 
90% of serum copper occurs in the complex with CP, while the remaining 10% is bound to albumin 
or amino acids [4]. Copper, when delivered to various organs, is utilized in metabolic processes by 
Cu-containing enzymes. Although various tissues differ in copper requirements, the set of proteins 
regulating copper distribution within the cells is thought to be the same in all tissues. On the other 
hand, excess cytosolic copper in hepatocytes is expelled into the bile and removed from the organism 
in feces. Only 2% of copper is removed from the body by the kidneys in urine [4,11,12].
3. Cellular Copper Uptake, Transport, and Utilization Are Orchestrated by a Closely Integrated 
Network of Proteins
Over the last three decades, a remarkable increase has been made in our understanding of the 
molecular mechanisms of copper homeostasis, as well as the structure and function of Cu-containing 
proteins. A real breakthrough was the discovery in 1993 of ATP7A and ATP7B proteins: Cu-transporting 
ATPases [13- 16]. Currently, we know that cellular copper homeostasis requires a series of copper 
importers, carriers, chaperones, recipient proteins, and exporters to achieve the essential level of 
this biometal and prevent its toxicity (summarized in Figure 1). Cellular copper uptake, transport, 
and utilization are coordinated by a closely integrated network of three groups of proteins.
The first group comprises copper transporters belonging to the CTR/SLC31 (copper transporter) 
family: CTR1 and CTR2 proteins that are involved in copper uptake and intracellular distribution. 
In mammalian cells, copper import is primarily mediated by the high-affinity copper membrane 
transporter CTR1 (more than 80% of intracellular copper import is CTR1-dependent). Although CTR1 
is ubiquitously expressed in tissues, its expression is especially high in the liver, kidneys, small intestine, 
ovaries, testes, and heart [17- 22]. CTR2, a second cellular copper transporter, exhibits exclusively 
intracellular localization. CTR2 is localized in the membranes of the vacuoles, vesicles, endosomes, 
and lysosomes of mammalian cells [17,20,23]. The major role of CTR2 is to facilitate copper release from 
degraded cuproenzymes in lysosomes and to transport it back into the cytosol for reutilization [17,20].
The second group comprises metallochaperones, cytosolic copper transporters that bind Cu 
ions and deliver them to the cellular organelles to prevent possible participation of Cu ions in the 
Fenton reaction [7,18]. These metallochaperones include among others an antioxidant 1 protein 
(ATOX1), which binds Cu+ ions and transports them from the Golgi apparatus to ATP7A and 
ATP7B proteins [3,7,24]. ATOX1-ATP7A and ATOX1-ATP7B interactions are essential for intracellular 
copper translocation and trafficking because ATOX1 also regulates the catalytical activities of 
both ATPases [24,25]. The copper chaperone for superoxide dismutase 1 (CCS) is a ubiquitously
expressed cytosolic metallochaperone, delivering Cu ions to Cu,Zn-SOD1 molecules in the cytoplasmic 
reticulum. By means of this function, CCS is responsible for the conversion of apo-SOD1 to the active 
holoenzyme [26- 29]. Cytochrome c oxidase copper chaperone (COX17) is a metallochaperone that 
binds Cu ions and transports them to mitochondria, where they are bound to subunits of cytochrome-c 
oxidase, an enzyme of complex IV of the mitochondrial respiratory chain. COX17 is a small, hydrophilic 
protein located in the cytoplasm and mitochondrial intramembrane space. COX17 is expressed in all 
tissues [30,31].
The third group comprises P-type Cu-transporting ATP-ases (ATP7A and ATP7B), localized 
in the trans-Golgi network (TGN). In the Golgi apparatus, ATP7A and ATP7B proteins transfer 
copper, using the energy of ATP hydrolysis, into the lumen of the secretory pathway where this 
metal is incorporated into the active sites of the Cu-dependent enzymes. Both ATP7A and ATP7B 
are also involved in the ATP-dependent transport of Cu ions across the plasma or intracellular 
membranes [3,17,25,32]. ATP7A and ATP7B are encoded by different genes localized in separate 
chromosomes. In humans and laboratory rodents, ATP7A protein is encoded by the X-linked ATP7A 
(Atp7a in rodents) gene and its expression has been reported in nearly all cells in the body [13- 15]. 
For this reason, ATP7A is considered to be a housekeeping gene. Nevertheless, its expression differs 
among the cells and tissues and is age-dependent [3,9,10,33]. The highest expression levels have been 
found in the brain, kidney, small intestine, and heart [3,34- 36]. In humans, lack of ATP7A activity 
caused by a mutation in the ATP7A gene leads to severe metabolic syndrome—Menkes disease [1].
ATP7B is encoded by the autosomal ATP7B  gene. In humans the ATP7B  gene is located on 
chromosome 13, in mice on chromosome 8 [16,37,38]. In mammals, ATP7B protein is primarily 
synthesized in the liver in the hepatocyte, but its expression has been also reported in other 
tissues such as the placenta, mammary gland, eye, lung, and brain [3,16,38]. ATP7B protein in 
hepatocytes is responsible for copper binding to apo-ceruloplasmin, resulting in the formation of the 
redox-active holo-ceruloplasmin, responsible for the transport of copper into the bloodstream. ATP7B 
also participates in the excretion of excess copper to the bile [39]. Besides the liver, ATP7B is also 
responsible for the return transport of copper from the placenta to the maternal compartment, to prevent 
excess copper accumulation in the fetus [40,41]. During lactation in mammary gland cells, ATP7B 
expression exhibits a granular, diffuse cytoplasmic pattern, and participates in copper export to the 
milk [42]. Mutation in the ATP7B gene results in disturbances in copper binding to ceruloplasmin (CP) 
by the ATP7B protein and leads to copper accumulation in the liver up to the toxic level in patients with 
Wilson disease [3,43]. In cells, ATP7A and ATP7B are found predominantly in membranes of the TGN 
and endocytic vesicles, and to a lesser extent at the plasma membrane. ATP7A and ATP7B circulate 
between these compartments in response to changes in intracellular copper levels. The Cu-dependent 
regulation of intracellular localization of ATPases determines the fate of this metal, which is either used 
for the biosynthesis of Cu-dependent enzymes in the secretory pathway or is sequestered in or released 
from vesicles into the extracellular milieu [25,38]. By means of different mechanisms, both ATP7A 
and ATP7B prevent toxic copper accumulation by expelling Cu ions from the cells. When the cells are 
exposed to increased copper concentrations, ATP7A moves to the cytoplasm and plasma membrane 
(in polarized cells to the basolateral membrane) [17,32,38,44]. Under the same conditions, ATP7B is 
transported to the plasma membrane in vesicles (in polarized cells to the apical membrane) [2,25,38]. 
It has been proposed that this Cu-induced trafficking of both ATPases is fundamental for maintaining 
cellular copper homeostasis [3]. Another important role of ATP7A involves delivering of Cu+ ions to the 
secretory pathway where they are incorporated into the Cu-dependent enzymes such as lysyl oxidase, 
tyrosinase, dopamine-ß-hydroxylase, peptidylglycine-a-amidating monooxygenase, and extracellular 
dismutase (SOD3) [3,45,46].
Figure 1. Copper metabolism in polarized mammalian cells. Cupric ions (Cu2+) are reduced to 
cuprous ions (Cu+) by metaloreductase and can then be transported into the cell by the transmembrane 
transporters CTR1 or CTR2. In the cytosol, Cu+ ions can be reversibly bound by metallothionein (MT) 
and stored in the Cu-MT complex. In the cytoplasm Cu+ ions are bound by cytosolic metallochaperones: 
copper chaperone for superoxide dismutase 1 (CCS), CO)X17, and. ATOX1, which deliver copper 
to various proteins such as superoxide dismutase 1 (SOD1), cytochrome c oxidase (CCO), ATP7A, 
and ATP7B. As a result, copper is delivered to different cellular compartments such as the cytoplasmic 
reticulum, mitochondria, or the Golgi apparatus. The ATPeA and ATP7B proteins located in the 
trans-Golgi network: (TGN) incorporate Cus iona into the apoenzymes. ATP7B can fiansfer copper to 
apo-ceruloplasmin (CP) to form holo-ceruloplasmin. Then copper in the complex with ceruloplasmin 
can be transported to file blood vessels. Cu-transporting ATPases can remove the excess copper outside 
the cell: ATP7A across the basolateral membrane and ATP7B across the apical membrane of polarized 
cells. This figure was created with BioRender.com.
4. Dysfunction of Spermatogenesis in Both Copper Overload and Deficiency
Although our knowledge of the molecular regulation of copper metabolism has dramatically 
increased over the psst 30 years, the precise molecular mechanisms of copper handling in the male 
reproductive system are still poorly understood. M oreover a vailable clinical data urgently wait 
for a belter explanation of the regulation of copper a cquisition end distribution within cells of the 
maie reproductive aystem. Results of numerous human and animal studies indieate that both testis 
structure; and the process of spermatogenesis (production, maturation, motility. and fertilizing capacity 
of the epermatozoa) are affected in response to increared copper concentration [47- 54]. It has been 
also reported that seminal plasma copper concentrations in oligozoospermic, asthenozoospermic, 
and azoospermic patients are significantly higher than in normozoospermic individuals [55]. 
Even in infertile men, exposure to high environmental copper concentration is associated with 
increased oxidative stress manifested by the increased total oxidant value in the seminal plasma [56].
Clinical manifestations associated with copper poisoning such as seminiferous tubule epithelium 
degradation [48,54], reduction in spermatozoa number [49], decreased spermatozoa motility [48,56], 
acrosome reaction inhibition [57], and increased apoptosis have been reported to reduce male 
fertility [47,48]. Moreover, decreased testosterone levels have been noticed in rats supplemented with 
a high copper diet [49]. In young male mice injected with small amounts of cupric chloride (CuCl2 ), 
the development of gonads was delayed in comparison to control mice [48]. In addition, in infertile and 
subfertile men, blood serum and seminal plasma copper concentrations were significantly higher than 
those in the fertile controls [28,53,54]. Conversely, there is strong evidence showing that Cu-deficient 
ram, rat, mouse, and goat males produce ejaculates of lower volume, lower spermatozoa concentration, 
poorer spermatozoa motility, and morphology. Histological analyses have demonstrated that the 
seminiferous tubules of Cu-deficient animals are less developed. This was mainly explained by 
the inactivation of the function of the Sertoli cells [48,50,58- 61]. All these data indicate that copper 
concentration and metabolism in male gonads must be very tightly regulated, starting from puberty 
and continuing progressively throughout adult life. Studies using the mouse model showed that in 
adult males, copper concentration in the testes (0.94 gg/g wet tissue) [48] is lower in comparison with 
other organs such as the brain (1.5 gg/g) [62], kidney (4.4 gg/g), and liver (4.94 gg/g) [10,12].
5. High-Affinity Copper Proteins from the CTR Family Facilitate Copper Transport to Both Sertoli 
and Germinal Cells
Copper is transported from the blood to the gonads and is distributed all over the organ through 
the capillary vessels. Up to now, it is unclear how copper is delivered from capillary vessels to 
seminiferous tubules. Importantly, seminiferous tubules are penetrated by neither blood nor lymph 
vessels. In rodents, seminiferous tubules are closely surrounded by tunica propria composed of 
fibroblasts and the myoid cell layer (shown in Figure 2 ) [63]. Many transporters expressed either in 
Sertoli cells or germinal cells act to facilitate the influx and/or efflux of metabolites and create a suitable 
environment for spermatogenesis [63,64]. The results of our recent study indicate an age-dependent 
regulation of the expression of copper transporter genes Slc31a1 and Slc31a2 (encoding CTR1 and CTR2 
proteins, respectively) in the mouse immature and mature male gonads [65]. CTR1 transports copper in 
the form of Cu+ ions in an ATP-independent manner using conserved methionine residues located in 
the N-terminal domain. Two-dimensional electron microscopy studies have demonstrated that CTR1 
forms a pore for the movement of Cu+ ions across membranes by the formation of homotrimers within 
the cell membrane [20,21]. Studies on mouse models provide evidence that within the seminiferous 
tubules of adult males, high-affinity copper transporter CTR1 mediates copper transport to both 
Sertoli cells and germinal cells [19,64,65]. In the cross-section of the testis, the expression of CTR1 
has been detected in spermatogonial cells and primary spermatocytes [64,65]. Therefore, it seems 
that CTR1 plays a major role in the supply of copper to premeiotic and early meiotic germinal cells. 
In addition, our findings revealed that in the mouse testis, expression of the Slc31a1 gene gradually 
increases from postnatal day 10 up to day 18 and its highest expression occurs between postnatal days 
18 and 22, when the primary spermatocytes are the most abundant cells in the seminiferous tubules. 
In the testes of 30-day-old males, a significant reduction in Slc31a1 gene expression was detected, 
indicating that it is lower when postmeiotic cells constitute a significant proportion of germ cells. 
This indicates that CTR1 supplies premeiotic and early meiotic germinal cells with copper necessary for 
maintenance of the meiosis process [65]. To examine the functional significance of CTR1 for the process 
of spermatogenesis, mice with conditional knock-out of the Slc31a1 gene in the germinal cells (CTR1agc 
mice) were generated [64]. In CTR1agc males, a marked reduction in the size of the testes was observed 
in the postnatal days 28 and 41. Histological evaluation of testes in CTR1agc mice revealed that in 
the seminiferous tubules of 28-day-old males the number of primary pachytene spermatocytes was 
strongly reduced. The presence of germ cells with condensed nuclei in the testes of CTR1agc mice 
strongly suggested that primary spermatocytes died through apoptosis [64]. In the seminiferous 
tubules of the 41-day-old CTR1agc males, the majority of germ cells died, while spermatogonia and
Sertoli cells were still present. All these data indicate that CTR1 expression in primary spermatocytes 
is critical for the process of spermatogenesis because it delivers large amounts of copper necessary 
for the correct course of meiotic division. Our results confirmed these observations and showed that 
during spermatogenesis progression in mouse gonads, copper concentration increases continuously, 
reaching the highest value at postnatal day 20, when meiotic germ cells are most prominent [65].
Figure 2. Localization of co pper-related proteins in the seminiferous tubule and myoid c ells. In the 
testes, gametes are produced during the multi-step process called spermatogenesis, which covers 
a complex network of regulations that occur in the seminiferous tubules. Each seminiferous tubule is 
surrounded by a few layers of myoid cells that border on blood vessels. The seminiferous epithelium 
contains the; Sertoli cells and the germ eells and. lies on the basal lamina. The lumen of the aeminiferous 
tubule is filled with seminal fluid. The Sertoli cells are polarized cells that reach the lumen of the 
seminiferous tubule and support the individual stages of developing germ cells. Serioli cells are linked 
by tight junctions that iorm a blood-testls bariier. This divides Ihe seminiferous epithelium into the 
adluminal and basal compartments and allows Sertoli cells to control the environment for developing 
late germ cells. The first stages of the gerne cell line Eire speemstogonia, which he on the basal lamina. 
Above them, primary and secondary speimatocytes are successfoely sihiated. The next stages are round 
spermatids, whfoh tsansfobminto elongated spermatids. After absorption of residual bodies, Sertoli 
cells release the elongated spermatids into the seminiferous tubule lumen where these spermatids 
become sperm. The transport of Cu ions during the process of spermatogenesis occurs between germ 
cells, Sertoli cells, and myoid cells. Spermatogonia, primary spermatocytes, and Sertoli cells absorb 
copper using CTR1. The excess copper is exportedlrom the primary spermatocyles arid Se rtoli cells 
through the ATP7A proiein. Presumebly a similar funclipn is performed by ATPdB in the elongated 
spermatids. Removed Cu+ ions are imported to Sertoli cells through CTR1. In Serioli cells and myoid 
cells, copper is dellvered to tire ceruloplasmin via ATP7B. In the complex with ceruloplasmin, Cu+ ions 
leave the myoid cells and enter the bloodstream. This figure was created with BioRender.com.
It is noteworthy that the Ctrl gene is eenservative in pukaryotes. Both yeast (Schizosaccharomyces 
pombe, S.pombe) and insect iDrosophila melanogasteri models highlight the importance of the Ctr protein 
in the import of copper to germinal cells during the process of meiosis. In yeast, the four proteins
Ctr4, Ctr5, Ctr6, and Mfc1 have been identified and characterized as copper transporters operating in 
meiotic cells. Among them, Ctr4, Ctr5, and Ctr6 are members of the CTR family of membrane copper 
transporters [66- 68]. It has been shown that in S. pombe during meiosis the copper transporters Ctr4 
and Ctr5 co-localize at the plasma membrane of zygotic cells shortly after the induction of meiosis 
under low copper conditions and play a critical role in the acquisition of this microelement from 
the environment [66,68]. In turn, Ctr6 localizes to vacuolar membranes in early meiosis and then 
undergoes redistribution in a time-dependent manner to reach forespore membranes where it persists 
until sporulation [66,68]. Ctr6 serves to mobilize intravacuolar stores of copper and participates in the 
delivery of copper to Sod1, a cytosolic Cu-dependent antioxidant enzyme in yeast [66,68]. In S. pombe 
the Mfc1 protein, a yeast homolog of mammalian CTR1, is necessary for the progression of meiotic cells 
through the first prophase. Importantly, functional similarities between yeast Mfc1 and mammalian 
CTR1 proteins have been demonstrated [69] . M fc1 is produced throughout the meiotic division and 
spore maturation process. Mfc1 localizes in the surrounding of the forespore membrane and its 
presence is required for copper accumulation into forespores and production of fully active copper 
amine oxidases [66,69]. Cells with a deficiency of Mca1 protein, an activator of Mfc1 gene transcription, 
are arrested at the first metaphase under Cu-deficient conditions [70]. Thus, it seems that a minimal 
copper level must be maintained to assure meiotic cell division in yeast. It is tempting to propose that 
a similar regulatory mechanism might act in mammalian meiotic cells.
In Drosophila melanogaster three Ctr1-like genes are expressed: Ctr1A, Ctr1B, and Ctr1C. The Ctr1A 
gene is constitutively and ubiquitously expressed. Its loss results in developmental arrest and 
in a general failure of Cu-dependent processes (cuproenzyme activity, neuropeptide maturation, 
heart function). The Ctr1B gene is responsible for copper uptake from the intestine. The Ctr1C gene has 
been proved to be necessary for copper transport into male germ cells. Results of immunohistochemical 
analysis revealed that its expression is restricted to the male germline cells. In the male gonads of 
wandering third instar larvae, Ctr1C expression has been found in spermatocyte cysts, and the Ctr1 
immunopositive signal gradually became stronger from early to late spermatocyte cysts [71]. Confocal 
analysis showed that the Ctr1C protein localizes to the plasma membranes of late spermatocyte cysts 
but is absent from early cysts, and this indicates that copper is delivered to the male meiotic germ cells. 
In the gonads of mature D. melanogaster males, Ct1rC protein is localized in the mature spermatozoa. 
Interestingly, loss of function of the Ctr1C gene in D. melanogaster male mutants (Ctr1C6D) did not lead 
to infertility. However, double male mutants lacking functional Ctr1B and Ctr1C proteins, in which the 
intraorganismal copper level is strongly reduced due to the impairment of intestinal absorption of the 
metal (caused by a mutation in the Ctr1B gene) are sterile [71]. All these data attest to the requirement 
of CTR/Ctr proteins for copper transport to the male germ cells during spermatogenesis and show that 
this process is very conservative between yeast, insects, and mammals and that copper delivery to the 
developing male germ cells is critical for the finishing meiosis.
In the mouse testis, apart from germ cells, expression of the Slc31a1 gene has also been reported 
in somatic cells such as Sertoli cells [19,64,65]. In the seminiferous tubules, Sertoli cells support, 
nourish, and protect spermatogenic cells using various signal pathways. In addition, tight junctions 
between adjacent Sertoli cells form a blood-testis barrier (BTB), building an environment optimal 
for the development of germ cells. The BTB regulates the free transport of metabolites, ions or 
harmful substances from entering the lumen of the seminiferous tubules and reaching the meiotic 
germ cells [63,64]. Immunohistochemical analysis has shown that CTR1 protein is localized along 
both the basal and adluminal compartments of the Sertoli cells [64,65]. To examine whether the loss 
of the Slc31a1 gene expression in Sertoli cells affects spermatogenesis, mice with specific disruption 
of this gene in these cells (CTR1asc males) were generated. Interestingly, in CTR1asc males copper 
concentration in the testes was reduced by about 40% [64]. This strongly suggests that copper can be 
delivered to the seminiferous tubules via the Sertoli cells equipped with basally localized CTR1. Copper 
deficiency in the gonads of CTR1asc males also leads to decreased activity of cytochrome c oxidase by 
up to 60% compared to that in the testes of wild-type (WT) males [64]. Despite the reduction in copper
concentration in the gonads of CTR1asc males, these animals were fertile. Moreover, when they were 
crossed with WT females to assess their fertility, no changes in the length of conception and the number 
of pups in the litter weoe observed [64]. In our studies, we also observed the CTR4 immunopositive 
signal in the lateral membrans of Serioli cells, localized close to the lumen of seminieerous tubuli 465]. 
We hypothesized that such localization of CTR1 protein m the Sertoli cells allows reabsorption of Cl u+ 
ions removed from the germinal cells by ATP7A and ATP7B copper fransporters. The expreosion and 
function of the CTR1 orotein in malr mouse gonads is summarized so Table 1.
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Little is known about the role of the CTR2 protein, a low-affinity cellular Cu+ ion importer
involved in the maintenance of copper homeostasis in the gonads. To check whether this protein is also 
involved in copper import into primary spermatocytes, we analyzed the testicular temporal expression 
profile of the Slc31a2 gene [65]. Results of the qRT-PCR analysis showed the lowest expression of this 
gene in the testes of 5- to 22-day-old males, but in 30-day-old and older animals, a significant increase 
in the Slc31a2 gene expression was observed. Our findings indicate that this gene is predominantly 
expressed when postmeiotic cells are abundant in the testes of mice [65] . The role of the CTR2 protein 
during spermatogenesis needs future investigation.
6. Complex Regulation of the S o d l  Gene Encoding Cu,Zn-Superoxide Dismutase (SOD1) in 
Male Gonads
For many years it has been believed that among various mammalian cell types, male germ cells 
are particularly vulnerable to excess copper [72,73]. Spermatogenesis is a process that consumes 
large amounts of oxygen. Testes are very susceptible to the reactive oxygen species due to the high 
content of unsaturated fatty acids in the membranes of testicular cells [74]. The ability of copper to 
react with partially reduced forms of O2 such as the superoxide anion (O2- ) and hydrogen peroxide 
(H2O2) may lead to the formation of the hydroxyl radical (OH), a highly destructive oxidant [74,75]. 
The first enzyme involved in the protection against oxidative damage is SOD1, which catalyzes the 
conversion of O 2 -  to H 2 O 2  and O 2  dismutation. Then, H 2 O 2  is metabolized by catalase (CAT) or, 
to a greater extent, by glutathione peroxidase (GPX) [74,76]. In mammalian somatic cells, SOD1 
protein is responsible for approximately 90% of total SOD (superoxide dismutase) activity [75]. In the 
male gonads, the Sod1 gene exhibits a specific and unusual expression pattern. In mouse testes,
Protein
C ell Type G erm  Cells Som atic Cells




three alternative transcripts, (0.73,0.80, and 0.93 kb), of the Sod1 gene have been found [77]. In somatic 
cells of the gonad, the 0.73 kb Sod1 (somatic, sSod1) transcript is synthesized whereas the 0.80 and 
0.93 kb Sod1 (testicular, tSod1) transcripts are specific only for the germ cells [77]. The sSod1 and tSod1 
transcripts differ in 5'UTR (untranslated region on the 5') structure [77]. The tSod1 transcripts contain 
an additional 114 nucleotides in the 5'UTR as compared with the sSod1 transcript [77].
In contrast to sSod1, tSod1 is translationally regulated during spermatogenesis. In testes, 
SOD1 translation is repressed in meiotic cells and SOD1 protein was found only in spermatogonia [73]. 
It has been proposed by Gu and Hecht, 1996, that translation of 0.93 kb testicular Sod1 transcript 
in the male gonads can be blocked by the 65 kDa protein, SOD-RBP (Cu,Zn-superoxide dismutase 
RNA-binding protein), which can be reversibly bound to the 5 'UTR of the tSod1 mRNAs [78]. 
The authors suggest that SOD-RBP recognizes a secondary structure formed by 114 additional 
nucleotides within the 5'UTR of tSod1 [78]. However, expression and activity of SOD1 have been found 
in elongated spermatids and spermatozoa in humans, mice, and in other mammalian species [79- 84]. 
Thus even if the expression of both 0.93 kb and, to a lesser extent, 0.80 kb Sod1 mRNAs in round 
spermatids was detected [77,78], they are translationally repressed and stored until the elongated 
spermatid stage. For normal activity, SOD1 needs to undergo maturation from apo-protein and 
monomer form to a functional dimeric holo-enzyme. During this process, apo-SOD1 requires zinc 
and copper and the formation of an intramolecular disulfide bond between two cysteines to form 
a homodimer [28,85]. SOD1 maturation is facilitated by CCS, which catalyzes the acquisition of Cu 
ions and the formation of a disulfide bond [27,28]. Thus, CCS plays a crucial role not only in SOD1 
metalation but also in SOD1 activation.
In the absence of metal cofactors and upon reduction of the disulfide bonds, the SOD1 dimer is 
destabilized and exists as an inactive monomer. Only when both metal ions are present and a disulfide 
bond is formed, the active, dimeric form of SOD1 is stabilized [27,28,85] . Analysis of the expression 
of the Ccs gene in the testes of young (immature) and adult (mature) mice revealed that its mRNA 
abundance in the testes of young males is relatively low in comparison to mature animals [65]. This can 
be explained by the fact that in the testes of young animals, Ccs is expressed mainly in somatic cells, 
in which the translation of sSod1 takes place. Increased Ccs expression in the testes of adult males 
indicates that both Sod1 transcripts (sSod1 and tSod1 in germ cells) are translated to support an efficient 
metalation of both apo-forms of SOD1 [65].
7. Role of ATP7A, Copper Transporting ATPase in the Protection of Premeiotic and Meiotic Germ 
Cells from Copper Toxicity
An important question arises as to the mechanism of preventing germinal cells (and in general 
the gonads) from the toxic effects of copper excess. A possible explanation has been provided by the 
analysis of the expression of Cu-transporting ATPases: ATP7A and ATP7B proteins in the mouse 
testes [65]. Cu-transporting ATPases are the only proteins that control cellular copper efflux in 
mammals. The expression levels of ATP7A and ATP7B are tissue- and organ-dependent and in some 
organs developmentally regulated [3,10,11,33,34]. In seminiferous tubules, ATP7A is expressed in the 
spermatocytes [65]. Quantitative analysis of the expression of the Atp7A  gene and ATP7A protein 
in mouse testes showed that the highest expression level of both gene and protein occurs in males 
between days 18 and 22 postpartum, when primary spermatocytes are the most prominent germ 
cells [65,86]. In the testes of adult mice, positive staining was observed in leptotene and pachytene 
spermatocytes but not in earlier or later stages of germ cells. Interestingly, the ATP7A protein has 
not been detected in the round and elongated spermatids [65]. All these data strongly suggest that 
the function of ATP7A is associated with the efflux of excess copper from male germ cells at the 
first prophase (mainly pachytene spermatocytes) to protect them against free radicals potentially 
generated by Cu ions. Indeed, increased copper concentration is toxic for germ cells because it 
contributes to oxidative damage to DNA including DNA oxidation, single and double-strand breaks, 
crosslinks and adducts, point mutations, and chromosome instability [87]. However, it is evident
that copper cannot be excessively exported from germ cells because its appropriate level is required 
for meiotic division [66,68]. Immunohistochemical studies have revealed that expression of ATP7A 
protein within seminiferous tubuli is not restricted to germ cells, but is also present in somatic Sertoli 
cells [65]. In the Sertoli cells, the ATP7A protein is localized close to the basolateral part of the 
seminiferous tubuli, indicating that this protein is involved in copper efflux possibly contributing 
to the protection of these cells from copper overload. Previous findings have also shown that in 
polarized cells, increased intracellular copper levels trigger relocalization of ATP7A to the basolateral 
cell membrane [3]. Localization of ATP7A in the Sertoli cell can suggest that in the testes, this protein 
participates in the regulation of copper concentration not only in germ cells but also in seminiferous 
tubules. As demonstrated in mice with mutations in the Atp7a gene, copper concentration in the testes 
is higher than in the wild genotype (WT) controls, and this finding supports the concept of ATP7A 
as a protein playing a role in the maintenance of copper homeostasis in the testes [48]. In general, 
our knowledge regarding ATP7A function originates mostly from studies on mouse models with 
different mutations within the X-linked Atp7a gene, called mottled mutants [12,88- 91]. To examine 
the role of ATP7A protein in the process of spermatogenesis, we used mice with the mosaic mutation 
(Atp7amo-ms) belonging to the group of mottled mouse models, recognized as animal models of Menkes 
disease [34,92]. In mosaic mice, the missense mutation c.2933G to C, in the Atp7a gene results in 
amino acid substitution Arg978Pro in the ATP7A protein [34]. M osaic mutant males exhibit many 
clinical features characteristic for defective copper metabolism, including defects in pigmentation 
and hair structure, decrease in body weight, poor viability, and progressive paresis of the hind 
limbs. Similarly to other mottled mutants, mosaic mice exhibit disturbances in copper transport 
and absorption. In mutant males, copper is accumulated in the small intestine and kidneys, but the 
brain, liver, and heart have been found to be Cu-deficient [92- 94]. Mutant males die at about days 16 
postpartum, but if treated with subcutaneous injection of cupric chloride (CuCl2 ) solution, they survive 
longer and some of them achieve remarkable longevity [12,48]. Lack of activity of the ATP7A protein 
in mosaic mutants leads to the accumulation of copper in the testes, especially in mutant males treated 
with CuCl2 [48]. Copper accumulation in the gonads of the mutants results in increased apoptosis 
of the germ cells in both young and adult males [48,95]. In the testes of the adult mosaic mutants, 
apoptotic cells have frequently been identified among spermatocytes; for comparison, in mature 
testes of WT mice, sporadic apoptotic cell death is observed and apoptosis is largely restricted to 
spermatogonia [48,96]. This observation supports our findings showing that ATP7A activity in primary 
spermatocytes is of key importance for germ cells at the stage of the first prophase [65]. Histological 
analysis of the gonads from adult mutants has revealed gonad injury manifested as a presence of 
atrophic and vacuolated and in some males sclerotic seminiferous tubuli. Despite these abnormalities, 
spermatogenesis continues and mutant males produce spermatozoa [48,95]. Nevertheless, analysis 
of gamete quality has revealed a statistically significant decrease in the percentage of motile sperm, 
live spermatozoa, normal morphology, and spermatozoa tail membrane integrity in comparison with 
wild-type genotype control [48]. All the results confirm that ATP7A protein plays an important role in 
the process of spermatogenesis and lack of its activity leads to gonad injury and poor quality of gamete 
production. The expression and function of ATP7A protein in male mouse gonads is summarized in 
Table 1.
8. Role of the ATP7B Copper-Transporting ATPase in the Regulation of Copper Concentration in 
Postmeiotic Germ Cells
In the testes, in contrast to ATP7A, which is expressed in premeiotic and meiotic cells, ATP7B protein 
is located only in the postmeiotic germ cells— elongated spermatids. Moreover, ATP7B protein has 
been observed in elongated spermatids bound to Sertoli cells [65]. We postulate that in the elongated 
spermatids, ATP7B-bound copper in the Golgi apparatus can be transported with vesicles to the 
cytoplasm. This has been described for hepatocytes, in which increased copper concentration induces 
ATP7B trafficking from the TGN to a subset of lysosomes, where ATP7B imports copper into the
lysosomal lumen and where the metal can be transiently stored [39] . It is possible that in elongated 
spermatids, the Cu-ATP7B complex is also transported to the lysosomal lumen and then removed 
from the cells with the residual cytoplasm, and can be engulfed by Sertoli cells [65]. In Sertoli cells, 
copper ions trapped in lysosomes might be taken up by the CTR2 transporter. Results of a quantitative 
analysis of the expression of the Slc31a2 and Atp7b genes have revealed that its expression significantly 
increases in the testes of 30-day-old male mice in which the process of spermiogenesis has started [65].
In the testes, ATP7B protein has also been found outside of seminiferous tubules in the myoid cells 
surrounding seminiferous tubuli, where the presence of CP has also been localized [65]. We postulate 
that in the myoid cells, ATP7B plays a biosynthetic role and participates in the binding of Cu+ ions to 
the apo-CP. In mammalian cells, CP is produced in two forms resulting from alternative splicing of 
exons 19 and 20 of the Cp gene [97]. The shorter form of CP, called a secretory CP, is the main protein 
transporting copper all over the organism, and is mainly produced by hepatocytes and secreted to the 
blood [97,98]. In the longer form of CP, the last five amino acids are replaced by 30 alternative residues, 
leading to the addition of the GPI (Glycosylphosphatidylinositol) anchor [97]. This GPI-CP form is 
located in the plasma membrane and plays the role of ferroxidase, which catalyzes the oxidation of 
Fe++ to Fe+++ and acts in conjunction with the only known mammalian iron exporter (ferroportin 
(FPN)) to mediate iron release from the cells. CP has been shown to co-localize with FPN within the 
cell membrane, forming a complex that allows Fe ions to be exported to the extracellular environment 
and to be loaded on transferrin, which binds only Fe+++ ions [99,100].
In the testes, expression of GPI-CP has previously been found in the Sertoli cells and it has been 
suggested that GPI-CP is related to transepithelial iron transport [101]. This suggestion is confirmed 
by a recent study showing that in the Sertoli cells, ferroportin is located in the basal membrane and it 
can participate in iron export from the seminiferous tubules [102]. In seminiferous tubules, both iron 
and copper should be kept at a low, physiologically constant level to protect the developing germ cells 
from copper/iron-induced oxidative damage. In conclusion, we suggest that the function of ATP7B in 
myoid cells might be associated with CP function and iron transport.
Copper transport in the male gonads and localization of the Cu-transporter in the seminiferous 
tubule are summarized in Table 1 and Figure 2.
9. Summary
Both copper deficiency and overload in the gonads are important conditions, which can negatively 
influence spermatozoa quality and reproductive function in humans and many other mammalian 
species [47- 50,53,54,64]. Results of experiments conducted on model organisms such as yeast, insects, 
and mice have revealed that during the process of gamete production an appropriate copper level is 
necessary for meiosis progression and subsequent cell reorganization to form mature spermatozoa. 
However, the increased copper level is toxic to germ cells. Therefore, organisms have developed 
tightly regulated molecular mechanisms responsible for adequate copper supply to the gonads and 
its transport to Cu-dependent enzymes, but also for the protection of testes from the toxic effects of 
copper overload.
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